The health technology assessment of bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy in Taiwan

Li-Ying Huang ,Shiuan-Ru Chen
Record ID 32018000375
Chinese (Mandarin)
Original Title: The health technology assessment of bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy in Taiwan
Authors' objectives: Based on the 2nd Generation NHI Act 42, health technology assessment (HTA) may be performed on new medical services (diagnostics and procedures) at the time of making reimbursement decisions. In addition to the considerations of human health, medical ethics, cost-effectiveness and health insurance finance are also major issues. Therefore, the aim of this study is to perform a comprehensive evaluation of these emerging treatments including bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy. The efficacy and economic literature of 6 surgical procedures was collected and synthesized by systematic review. The report UK, Canada and Australia, as well as international experience through the network of INAHTA were assessed. In addition, domestic status such as clinical application, distribution, prices, and cost analysis was investigated through questionnaires and qualitative interview.
Authors' results and conclusions: Our research found that most evidence is related to the comparison of bipolar and monopolar TURP. Cost-utility analysis with a Markov model framework was conducted to evaluate the cost-effectiveness of these procedures. Our evaluation concludes that bipolar TURP appears to be comparable effective and safer (reduction of TUR syndrome by 78%) in compared to monopolar TURP. The results also showed that the bipolar TURP maybe a cost-effective option. If this procedure is included in the NHI, the budget impact was estimated to be about 50 million to 200 million NTD.
Authors' recomendations: The assessment results shown above in respect of several dimensions could be served as an important information for decision makers of NHIA to appraise the value of transurethral prostate surgeries in Taiwan and then make decisions on reimbursement or not.
Authors' methods: Therefore, the aim of this study is to perform a comprehensive evaluation of these emerging treatments including bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy. The efficacy and economic literature of 6 surgical procedures was collected and synthesized by systematic review. The report UK, Canada and Australia, as well as international experience through the network of INAHTA were assessed. In addition, domestic status such as clinical application, distribution, prices, and cost analysis was investigated through questionnaires and qualitative interview.
Details
Project Status: Completed
Year Published: 2020
URL for published report: https://www.cde.org.tw/
Requestor: National Health Insurance Administration
English language abstract: An English language summary is available
Publication Type: Full HTA
MeSH Terms
  • Transurethral Resection of Prostate
  • Prostatectomy
  • Prostatic Hyperplasia
  • Cost-Benefit Analysis
  • Laser Therapy
Keywords
  • health technology assessment
  • transurethral resection of the prostate(TURP)
  • bipolar TURP
  • laser prostatectomy
  • benign prostatic hyperplasia (BPH)
  • cost-effectiveness analysis
  • budget impact analysis
Contact
Organisation Name: Center for Drug Evaluation
Contact Address: 3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name: Li Ying (Grace) Huang
Contact Email: lyhuang277@cde.org.tw
Copyright: Center of Drug Evaluation (CDE), Taiwan
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.